RESUMEN
In this research, the visible light active performance of Bi2ZnB2O7 (BBZO) was significantly enhanced through the formation of a composite with few layer MoS2. The resultant MoS2@BBZO catalyst was employed in both photocatalysis and photodetector applications. Comprehensive structural and morphological analyses of the MoS2@BBZO catalyst were conducted using X-ray diffraction (XRD), Raman spectroscopy, field-emission scanning electron microscopy (FE-SEM), and transmission electron microscopy (TEM). The estimated band gaps of BBZO and the composite were found to be 2.8 eV and 1.74 eV, respectively. Rhodamine B degradation studies demonstrated that the catalyst achieved 75% degradation within 30 minutes. Additionally, the photodetector application was investigated, revealing rapid photo-switching capabilities and an increased photocurrent.
RESUMEN
BACKGROUND: Resource-limited settings like India need a simple, quick, and temperature-independent point-of-care diagnostic test that can diagnose tuberculous meningitis (TBM) at the earliest. METHODS: A prospective study was carried out at a tertiary care center in North India wherein 50 subjects suspected of TBM were recruited and followed up for six months between January 2019 and December 2020. The aim was to evaluate the performance of loop-mediated isothermal amplification (TB-LAMP) in diagnosing TBM as compared to a composite reference standard (CRS), mycobacteria growth indicator tube 960 (MGIT 960) culture, and GeneXpert®. RESULTS: Out of 50 patients, 32 were TBM cases (64%), and 18 were non-TBM cases (36%). The sensitivity of TB-LAMP and GeneXpert® for TBM diagnosis against CRS was 53% (17/32) for both, and the specificity was 78% (14/18) and 89% (16/18), respectively. On comparing TB-LAMP against GeneXpert® for TBM diagnosis, the two methods had almost perfect agreement (Cohen's kappa=0.83) with statistical significance (p<0.001). CONCLUSION: The performance of TB-LAMP assay is comparable to GeneXpert® in diagnosing TBM, and it may be used as a substitute for CSF GeneXpert® in resource-limited settings.
RESUMEN
This study proposes the design of a micro-spiral-shaped piezoelectric energy harvester that scavenges energy from blood pressure variation in the cardiac cycle. The harvester can be a miniaturized perennial source of power that could even eliminate the need for replacement of conventional batteries used in current pacemaker technology. The concept of a 25 µm thin spiral-based piezoelectric energy harvester with a diameter of 6 mm satisfying the dimensional constraints has been proposed. A number of lead-free materials have been used along with Pb[Zr x Ti1- x ]O3 (PZT-5A) to compare the performance. The harvester has been designed in such a way that the natural frequency of the structure remains in the range of 1.1-1.3 Hz, which is equivalent to 66-78 heart beats min-1 of humans. The obtained alternating electric current from piezoelectric materials is converted into direct current. The maximum open-circuit voltage obtained is ≈0.9 V, which is not sufficient for charging a pacemaker battery. Therefore, boost converter circuit is employed to step up the voltage. It is found that K0.475Na0.475Li0.05(Nb0.92Ta0.05Sb0.03)O3 (KNLNTS) has the best performance as compared to other materials under study. The boosted voltage obtained from KNLNTS is ≈6 and ≈7 V for 80 and 90% duty cycle, respectively, which are sufficient for pacemaker battery charging.